Total Payments
$7,227
2021 Payments
$248.45
Companies
10
Transactions
104
Medicare Patients
3,498
Medicare Billing
$5.8M
Payment Breakdown by Category
Other$2,700 (37.4%)
Food & Beverage$2,030 (28.1%)
Consulting$1,463 (20.2%)
Travel$1,014 (14.0%)
Education$20.62 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $2,700 | 1 | 37.4% |
| Food and Beverage | $2,030 | 95 | 28.1% |
| Consulting Fee | $1,463 | 1 | 20.2% |
| Travel and Lodging | $1,014 | 6 | 14.0% |
| Education | $20.62 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Horizon Therapeutics plc | $3,308 | 17 | $0 (2021) |
| Cardinal Health 108, LLC | $2,208 | 7 | $0 (2018) |
| Horizon Pharma plc | $900.07 | 61 | $0 (2018) |
| AbbVie, Inc. | $180.66 | 6 | $0 (2019) |
| Amgen Inc. | $145.62 | 2 | $0 (2021) |
| GENZYME CORPORATION | $140.48 | 4 | $0 (2018) |
| Celgene Corporation | $125.94 | 1 | $0 (2018) |
| Genentech USA, Inc. | $124.56 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $75.34 | 4 | $0 (2020) |
| PFIZER INC. | $18.76 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $248.45 | 2 | Amgen Inc. ($125.00) |
| 2020 | $14.85 | 1 | E.R. Squibb & Sons, L.L.C. ($14.85) |
| 2019 | $3,364 | 22 | Horizon Therapeutics plc ($3,184) |
| 2018 | $2,963 | 47 | Cardinal Health 108, LLC ($2,208) |
| 2017 | $636.85 | 32 | Horizon Pharma plc ($381.62) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/09/2021 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $123.45 | General |
| Category: KRYSTEXXA | ||||||
| 07/08/2021 | Amgen Inc. | Enbrel (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Inflammation | ||||||
| 03/11/2020 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $14.85 | General |
| Category: Immunology | ||||||
| 12/10/2019 | AbbVie, Inc. | Rinvoq (Biological) | Food and Beverage | In-kind items and services | $9.56 | General |
| Category: Immunology | ||||||
| 12/05/2019 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $6.08 | General |
| Category: PENNSAID | ||||||
| 11/12/2019 | AbbVie, Inc. | Rinvoq (Biological) | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: Immunology | ||||||
| 09/19/2019 | AbbVie, Inc. | Rinvoq (Biological) | Food and Beverage | In-kind items and services | $3.60 | General |
| Category: Immunology | ||||||
| 09/18/2019 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $22.30 | General |
| Category: Immunology | ||||||
| 09/12/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $49.00 | General |
| Category: KRYSTEXXA | ||||||
| 09/12/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $23.88 | General |
| Category: KRYSTEXXA | ||||||
| 09/12/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Travel and Lodging | Cash or cash equivalent | $8.00 | General |
| Category: KRYSTEXXA | ||||||
| 09/09/2019 | Horizon Therapeutics plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $6.63 | General |
| Category: DUEXIS | ||||||
| 09/01/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Honoraria | Cash or cash equivalent | $2,700.00 | General |
| Category: KRYSTEXXA | ||||||
| 09/01/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Travel and Lodging | Cash or cash equivalent | $348.30 | General |
| Category: KRYSTEXXA | ||||||
| 08/27/2019 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $119.41 | General |
| Category: Immunology | ||||||
| 06/20/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $6.32 | General |
| Category: KRYSTEXXA | ||||||
| 05/29/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $4.50 | General |
| Category: KRYSTEXXA | ||||||
| 05/13/2019 | Horizon Therapeutics plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $3.31 | General |
| Category: DUEXIS | ||||||
| 05/07/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $2.57 | General |
| Category: KRYSTEXXA | ||||||
| 04/15/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $4.63 | General |
| Category: KRYSTEXXA | ||||||
| 04/10/2019 | E.R. Squibb & Sons, L.L.C. | ORENCIA (Biological) | Food and Beverage | Cash or cash equivalent | $16.62 | General |
| Category: Immunology | ||||||
| 03/18/2019 | Horizon Therapeutics plc | PENNSAID (Drug) | Food and Beverage | In-kind items and services | $3.52 | General |
| Category: PENNSAID | ||||||
| 02/26/2019 | Horizon Therapeutics plc | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $3.43 | General |
| Category: KRYSTEXXA | ||||||
| 02/19/2019 | Horizon Therapeutics plc | DUEXIS (Drug) | Food and Beverage | In-kind items and services | $3.20 | General |
| Category: DUEXIS | ||||||
| 01/23/2019 | Horizon Therapeutics plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: RAYOS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 10 | 1,070 | 265,973 | $3.8M | $1.8M |
| 2021 | 13 | 1,396 | 254,365 | $4.4M | $2.3M |
| 2020 | 13 | 1,032 | 210,619 | $2.9M | $1.7M |
Total Patients
3,498
Total Services
730,957
Medicare Billing
$5.8M
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 60 | 236,800 | $2.4M | $1.1M | 44.3% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2022 | 16 | 9,250 | $594,700 | $321,601 | 54.1% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 163 | 17,460 | $583,860 | $299,263 | 51.3% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2022 | 60 | 1,168 | $101,616 | $65,390 | 64.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 273 | 462 | $69,300 | $40,222 | 58.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 187 | 268 | $29,480 | $16,921 | 57.4% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 21 | 120 | $19,200 | $11,718 | 61.0% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 104 | 104 | $4,472 | $3,749 | 83.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 171 | 310 | $6,200 | $3,156 | 50.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 15 | 31 | $2,480 | $1,610 | 64.9% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2021 | 61 | 223,200 | $2.9M | $1.3M | 46.1% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2021 | 16 | 11,375 | $749,600 | $467,730 | 62.4% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 189 | 17,100 | $510,180 | $288,065 | 56.5% |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | Office | 2021 | 61 | 1,116 | $97,092 | $69,049 | 71.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 377 | 573 | $85,950 | $56,234 | 65.4% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 26 | 195 | $31,200 | $21,112 | 67.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 216 | 251 | $27,610 | $17,642 | 63.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 66 | 66 | $12,540 | $7,309 | 58.3% |
| 77080 | Bone density measurement of the core or central skeleton (e.g., hips, pelvis, spine) | Office | 2021 | 137 | 137 | $5,891 | $5,169 | 87.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 193 | 292 | $5,840 | $3,215 | 55.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 13 | 13 | $3,380 | $1,890 | 55.9% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 20 | 23 | $1,679 | $1,044 | 62.2% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2021 | 21 | 24 | $600.00 | $198.34 | 33.1% |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2020 | 59 | 197,600 | $2.2M | $1.3M | 57.8% |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 2020 | 14 | 5,575 | $357,250 | $248,758 | 69.6% |
About Dr. John Gresh, MD
Dr. John Gresh, MD is a Specialist healthcare provider based in Ocala, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/11/2005. The National Provider Identifier (NPI) number assigned to this provider is 1700888559.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Gresh, MD has received a total of $7,227 in payments from pharmaceutical and medical device companies, with $248.45 received in 2021. These payments were reported across 104 transactions from 10 companies. The most common payment nature is "Honoraria" ($2,700).
As a Medicare-enrolled provider, Gresh has provided services to 3,498 Medicare beneficiaries, totaling 730,957 services with total Medicare billing of $5.8M. Data is available for 3 years (2020–2022), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Ocala, FL
- Active Since 08/11/2005
- Last Updated 01/29/2014
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1700888559
Products in Payments
- KRYSTEXXA (Biological) $3,274
- KRYSTEXXA (Drug) $783.98
- Humira (Biological) $159.32
- Otezla (Drug) $125.94
- KEVZARA (Drug) $125.77
- Enbrel (Biological) $125.00
- Actemra (Biological) $124.56
- PENNSAID (Drug) $105.75
- ORENCIA (Biological) $75.34
- Rinvoq (Biological) $21.34
- RAYOS (Drug) $19.23
- XELJANZ (Drug) $18.76
- RHEUMATOID ARTHRITIS DISEASE (Drug) $14.71
- DUEXIS (Drug) $13.14
- VIMOVO (Drug) $11.59
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Ocala
Paul Jo, Md, MD
Specialist — Payments: $38,061
Specialist $38,061
Thimmiah Kumar, M. D, M. D
Specialist — Payments: $7,870
Specialist $7,870
Vishnu Reddy, M. D, M. D
Specialist — Payments: $4,789
Specialist $4,789
Amruth Bapatla, Md, MD
Specialist — Payments: $3,858
Specialist $3,858
Dr. James Paraiso, Do, DO
Specialist — Payments: $3,042
Specialist $3,042
Dr. Samantha Johnson, Dnp, DNP
Specialist — Payments: $2,174
Specialist $2,174